Major US Panel to Cast Ballots on Changing Baby Hepatitis B Vaccine Recommendation
Following a hold-up and an unusually contentious meeting, a government vaccine expert group was set to cast ballots on Friday on whether to change the long-held guideline that every infant be immunized against hepatitis B.
Heated Debate and a Postponed Decision
The first day of the conference on Thursday was characterized by heated debate over restricting access to the hepatitis B vaccine for babies and a choice to postpone the decision by a day to give members more time to scrutinize the phrasing. The panel, which counsels the Centers for Disease Control and Prevention on vaccination protocols, had twice before postponed.
“Is there any specific evidence of damage of giving this immunization before 30 days? Or is this theory?” asked one adviser.
In response, another attendee stated, “There is inadequate data about the long-term risk.”
Current Guidelines and Possible Consequences
The injection is presently advised for every newborn within 24 hours of birth to halt contraction of hepatitis B, which can lead to major damage to the liver. It has been provided to over a billion individuals for more than three decades.
The Atlanta conference provided no new evidence of harms caused by the vaccine. Authorities state any change to the current hepatitis B vaccination schedule could have major and extensive implications for pediatric well-being in the United States.
Group Membership and New Appointments
The advisory panel can only provide advice to the director of the CDC. The committee's composition has seen shifts in recent days, with the statement that the group's former head would depart for an official role and be substituted with a cardiologist who has been questioning of other inoculations.
The committee includes multiple immunization doubters who align with a goal to reform – and perhaps, in some cases, abolish – longstanding immunization guidelines.
